Ori News, Insights & Publications.

Insights |

Improving Patient Access to Cell Therapy Through Decentralized Manufacturing

By Jason C. Foster - Decentralized manufacturing could transform …

Insights |

Payer Challenges for Patient Access to Autologous Cell and Gene Therapies

By Jason C. Foster - Autologous cell and gene therapies …

News |

Frontrunners in Automated Cell and Gene Therapy Manufacturing

UK-based Ori Biotech launched its IRO platform developed in 2024 …

News |

Ori Biotech, Charles River Cell Therapy Manufacturing Platform Collaboration Yields Promising Results

The next-generation IRO platform was found to significantly outperform the …

News |

Charles River and Ori Biotech collaborate on CAR-T production

Ori’s IRO platform for cell-therapy manufacturing has yielded positive results …

News |

Ori doubles down on Charles River collaboration with promising new data on its automated cell therapy platform 

Just a few months after the reveal of Ori Biotech’s …

News |

Looking to the Future of Cell and Gene Therapy Manufacturing With  Ori Biotech and CTMC    

New Platform, New Potential. We get the background on a new …

News |

Left in limbo: When pharma halts rare disease research

One company that is trying to tackle high manufacturing costs …

News |

Ori unveils CGT platform to combat manufacturing challenges

London-based cell and gene therapy (CGT) focused firm, Ori Biotech …

News |

Rx Rundown: Merck, Johnson & Johnson, Danforth Advisors and more

Ori Biotech announced the commercial launch of its next-generation platform …

News |

Cytiva’s new platform rollout news came the same day Ori Biotech announced its IRO platform that automates, digitizes and standardizes the labor-intensive pars of the cell and gene therapy manufacturing workflow

Cytiva’s new platform rollout news came the same day Ori Biotech announced …

News |

Ori Biotech unveils new platform to address growing advanced therapy market

Cell and gene therapy (CGT) manufacturing specialist Ori Biotech has …